Salas Antonio Porthos, Lara-Albisua José L Pérez, Castillo-Amaya Carlos, Miranda-Enríquez Carlos A, Peña-Tijerina Raul, Quispe Juan Carlos, Mazek Jacek
Arthrosc Tech. 2025 Jan 22;14(5):103415. doi: 10.1016/j.eats.2024.103415. eCollection 2025 May.
In the past 10 to 15 years, there has been an increasing interest in using orthobiologics to address pathologies of the hip. The use of bone marrow aspirate concentrate (BMAC) showed greater functional improvement in patients with moderate cartilage injuries who had a labral repair than patients without BMAC injection. In hip arthroscopy and preservation, difficulty is encountered during the bone marrow harvest and administration into the hip joint with distraction. Therefore, orthopaedic surgeons need a reliable and reproducible technique to safely administer BMAC in the hip joint to achieve the best results. With this technique, we want to show that BMAC harvest and administration with a neonatal nasogastric feeding tube is easy, safe, and reproducible.
在过去10到15年里，人们对使用骨科生物制剂治疗髋关节疾病的兴趣与日俱增。对于接受盂唇修复的中度软骨损伤患者，使用骨髓抽吸浓缩物（BMAC）比未注射BMAC的患者功能改善更明显。在髋关节镜检查及保髋手术中，骨髓采集及在髋关节牵引状态下注入时会遇到困难。因此，骨科医生需要一种可靠且可重复的技术，以便在髋关节中安全地注入BMAC，从而取得最佳效果。通过这项技术，我们旨在表明，使用新生儿鼻饲管进行BMAC采集和注入简便、安全且可重复。
